OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its 'ION free' Large Diameter Head Dual Mobility Acetabular Cup System
By Omnilife Science Inc., PRNETuesday, March 9, 2010
EAST TAUNTON, Massachusetts, March 10, 2010 - OMNIlife science, Inc., is very pleased to announce that it has entered
into an exclusive U.S. distribution agreement with Societe d'Etudes
Recherches Fabrication (SERF)-Dedienne Sante of France for its NOVAE(R) Dual
Mobility Acetabular Cup System. OMNI intends to begin distribution of this
product in the USA as soon as U.S. FDA approval of the product is achieved.
"Gaining the distribution rights to SERF's NOVAE(R) line of Dual Mobility
Acetabular Cups will allow OMNI to provide its customers with access to large
head hip articulation technology that is free from the risk of metal ION
release. The SERF Dual Mobility Cup System has a successful clinical history
of over 30 years with outstanding implant longevity and extremely low
complication rates. Combining this Ion Free, Large Head Dual Mobility
Acetabular Cup technology with OMNI's advanced Apex Modular(TM) and K2
Modular hip stems as well as the new Apex ARC(TM) Tissue Sparing Hip Stem
systems will, upon FDA approval, provide OMNI with the ability to compete
against the Metal on Metal large head acetabular cup technology of our
competitors without the risks that have recently been associated with Metal
on Metal bearing surfaces," said George Cipolletti OMNI's president and CEO.
Nik Nikolaev, Chairman of Orthopaedic Synergy, Inc., the holding company
that owns OMNIlife science, Inc. and Enztec, Ltd., states, "Our distribution
arrangement with SERF is in keeping with our philosophy of providing the best
technology to our customers whether developed in house by our own family of
companies or by partnering with very high quality manufacturers such as
SERF-Dedienne Sante."
About OMNIlife science, Inc.
OMNIlife science, Inc. was founded in 1999 as an organization committed
to the design, manufacture and distribution of high quality orthopaedic
devices. Our corporate headquarters are located in East Taunton,
Massachusetts. Our products are prescribed by orthopaedic surgeons for their
patients who require total joint replacement. OMNI is ISO 13485 certified and
its products are FDA cleared and CE approved. OMNI is emerging as a leader in
modular hip stem technology and total knee replacement systems. We continue
to challenge the design and functionality of our products based on continued
advances in reconstructive surgical techniques, anatomic and biomechanical
data, as well as input from surgeons. Our corporate strategic objectives
include continued growth through line extensions to our hip and knee product
offerings as well as the introduction of new products that will complement
our current product portfolio and allow us to provide new clinical options
for our customers.
About SERF-Dedienne Sante
SERF-Dedienne Sante is a French medical implant Company with a long
experience in the design, manufacturing and distribution of orthopedic and
dental implants. Headquartered near Lyon-France, the Company has two
manufacturing plants in Lyon and Montpellier. Since 1973, SERF-Dedienne Sante
has pioneered several important developments in orthopaedic and dental
technology, the most successful being the Dual Mobility Acetabular Cup
Concept invented by Pr. Gilles Bousquet in the mid 1970's and which is
currently generating a tremendous interest from the orthopedic community
based upon excellent widely published long term clinical results. The Company
is ISO 13485 & ISO 9001 certified and its products are CE marked. Thanks to
its invaluable experience, flexibility, dynamic R&D and competitive
manufacturing, SERF-Dedienne Sante is now expanding its strong European
position to North America and Asia Pacific markets.
Further Information www.OMNIls.com www.dedienne-sante.com www.serf.fr
Mr. David LaSalle, +1-508-824-2444
Tags: East Taunton, March 10, Massachusetts, Omnilife Science Inc., Western Europe